Bank of Montreal
CDTX

Bank of Montreal’s Cidara Therapeutics CDTX Stock Holding History

Bank of Montreal’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-58
Closed -$3K – 3864
2021
Q1 		$3K Sell
58
-227
-80% -$11.2K ﹤0.01% 4806
2020
Q4 		$14K Sell
285
-9,099
-97% -$453K ﹤0.01% 4562
2020
Q3 		$558K Sell
9,384
-770
-8% -$54.4K ﹤0.01% 2287
2020
Q2 		$759K Buy
10,154
+549
+6% +$35.6K ﹤0.01% 2058
2020
Q1 		$459K Buy
9,605
+650
+7% +$38.9K ﹤0.01% 2016
2019
Q4 		$688K Buy
+8,955
New +$410K ﹤0.01% 2487
2016
Q3 		– Sell
-5
Closed -$1K – 4031
2016
Q2 		$1K Hold
5
– – ﹤0.01% 3964
2016
Q1 		$1K Hold
5
– – ﹤0.01% 4051
2015
Q4 		$2K Buy
+5
New +$1.5K ﹤0.01% 3969
2015
Q3 		– Sell
-400
Closed -$112K – 3990
2015
Q2 		$112K Buy
+400
New +$123K ﹤0.01% 2694

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Bank of Montreal's CDTX Position: Q2 2021 in Review

Bank of Montreal sold out of Cidara Therapeutics (CDTX) in Q2 2021, closing a stake of 58 shares — an estimated $3K sold.

Bank of Montreal first reported a position in CDTX in Q2 2015 and held it in 10 quarters. The position peaked at $759K in Q2 2020. 55 funds tracked by Wall St. Rank hold CDTX as of Q2 2021.

  • Bank of Montreal reported no remaining Cidara Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 58 Cidara Therapeutics shares in Q2 2021, an estimated $3K.
  • Bank of Montreal first reported a position in Cidara Therapeutics in Q2 2015 and held it in 10 quarters.
  • Bank of Montreal's Cidara Therapeutics position peaked at $759K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.